Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qun-Ying Yue

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Vaccine: X|November 8, 2021
Appendicitis as a possible safety signal for the COVID-19 vaccinesJoseph Mitchell, Qun-Ying Yue
International Immunopharmacology|October 12, 2020
Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBaseQingxia Zhang, Qun-Ying Yue
Drugs - Real World Outcomes|March 2, 2022
Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill CriteriaQun-Ying Yue, Pia Caduff-Janosa
European Journal of Clinical Pharmacology|January 28, 2024
Dabigatran-related serious medication errors: an analysis using data from VigiBaseQingxia Zhang, Qian Ding, Qun-Ying Yue
Drug, Healthcare and Patient Safety|December 13, 2018
Clinical factors predicting drug-induced liver injury due to flucloxacillinMikaela Lindh, Pär Hallberg, Qun-Ying Yue, et al.
Frontiers in Pharmacology|January 10, 2022
Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBaseQingxia Zhang, Qian Ding, Suying Yan, et al.
Clinical Medicine Insights. Cardiology|January 9, 2019
Fusidic Acid: A Neglected Risk Factor for Statin-Associated MyopathyJosefine Rönnqvist, Pär Hallberg, Qun-Ying Yue, et al.
European Journal of Clinical Pharmacology|July 1, 2022
Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBaseQingxia Zhang, Qian Ding, Suying Yan, et al.
Drug Safety|June 1, 2022
Montelukast and Nightmares: Further Characterisation Using Data from VigiBaseSarah Watson, Elenor Kaminsky, Henric Taavola, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilanceLuis Pinheiro, Kevin Blake, Justina Januskiene, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Vaccine: X|November 8, 2021
Appendicitis as a possible safety signal for the COVID-19 vaccinesJoseph Mitchell, Qun-Ying Yue
International Immunopharmacology|October 12, 2020
Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBaseQingxia Zhang, Qun-Ying Yue
Drugs - Real World Outcomes|March 2, 2022
Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill CriteriaQun-Ying Yue, Pia Caduff-Janosa
European Journal of Clinical Pharmacology|January 28, 2024
Dabigatran-related serious medication errors: an analysis using data from VigiBaseQingxia Zhang, Qian Ding, Qun-Ying Yue
Drug, Healthcare and Patient Safety|December 13, 2018
Clinical factors predicting drug-induced liver injury due to flucloxacillinMikaela Lindh, Pär Hallberg, Qun-Ying Yue, et al.
Frontiers in Pharmacology|January 10, 2022
Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBaseQingxia Zhang, Qian Ding, Suying Yan, et al.
Clinical Medicine Insights. Cardiology|January 9, 2019
Fusidic Acid: A Neglected Risk Factor for Statin-Associated MyopathyJosefine Rönnqvist, Pär Hallberg, Qun-Ying Yue, et al.
European Journal of Clinical Pharmacology|July 1, 2022
Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBaseQingxia Zhang, Qian Ding, Suying Yan, et al.
Drug Safety|June 1, 2022
Montelukast and Nightmares: Further Characterisation Using Data from VigiBaseSarah Watson, Elenor Kaminsky, Henric Taavola, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilanceLuis Pinheiro, Kevin Blake, Justina Januskiene, et al.
Pageof 3